# Revising ANDA  Labeling Following  Revision of the RLD  Labeling Guidance for Industry:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/revising-anda-labeling-following-revision-of-the-rld-labeling-guidance-for-industry-guidance-for-industry/806edfce-5e20-40ff-b54f-bbaca98cdfba

> FDA guidance document: Revising ANDA  Labeling Following  Revision of the RLD  Labeling Guidance for Industry:  Guidance for Industry. Issue date: January 24, 2024. Get complete insights and analysis.

---

## Details

- Title: Revising ANDA  Labeling Following  Revision of the RLD  Labeling Guidance for Industry:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2024-01-24
- Comment Close Date: 2022-03-25
- Last Changed: 2024-01-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-0092 ">FDA-2022-D-0092 </a>

## Related Documents

- [Requests for Reconsideration at the Division Level Under GDUFA](https://www.globalkeysolutions.net/guidances/guidance-document/requests-for-reconsideration-at-the-division-level-under-gdufa/57f559b5-e6c3-492b-91fd-01762f90e676)
- [Controlled Correspondence Related to Generic Drug Development](https://www.globalkeysolutions.net/guidances/guidance-document/controlled-correspondence-related-to-generic-drug-development/55babf6e-6cea-4e6c-80f6-3892feff9aab)
- [Good ANDA Submission Practices Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/good-anda-submission-practices-guidance-for-industry/c4f8f27a-3522-470b-8889-206366ebc0e7)